Abstract
Heart failure with preserved ejection fraction (HFpEF) represents a major unmet clinical need with limited treatment options. Implantable interatrial shunt devices have shown favorable safety and efficacy signals; however, they require permanent implantation to maintain shunt patency.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have